Effects of cardiac rehabilitation on inflammatio
Not Applicable
Completed
- Conditions
- Diseases of the circulatory system.Ischaemic heart diseasesI20-I25
- Registration Number
- IRCT201610085136N3
- Lead Sponsor
- Vice Chancellor Of Research Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
Exclusion criteria: Patients were excluded if they have congestive failure; immnomodulatory or anti-inflammatory medications other than Aspirin; or known history of immune related disorders; unstable angina; resting systolic blood pressure >200 mmhg or diastolic blood pressure>10mmhg; uncontrolled bradycardia or tachycardia.
history of CABG and PCI; have ability to present in cardiac rehabilitation program; not having any physical exercise out of cardiac rehabilitation program; cardiac rehabilitation start 2 month after CABG and 1 month after PCI
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PTX3. Timepoint: before and 30 min after one session submaximal aerobic exercise, and after 8 weeks cardiac rehabilitation program. Method of measurement: Human Pentraxin 3 Elisa Kit 96t - Zellbio Germany.;VCAM-1. Timepoint: before and 30 min after one session submaximal aerobic exercise, and after 8 weeks cardiac rehabilitation program. Method of measurement: Human VCAM-1 Elisa Kit 96t - Diaclone France.;CRP. Timepoint: before and 30 min after one session submaximal aerobic exercise, and after 8 weeks cardiac rehabilitation program. Method of measurement: Pars Azmon kit.
- Secondary Outcome Measures
Name Time Method Weight. Timepoint: before and after intervention. Method of measurement: balance scales.;Body mass index. Timepoint: before and after intervention. Method of measurement: weight divided by height square(kg/m2).;Fasting blood glucose. Timepoint: before and after intervention. Method of measurement: blood analysis.;Blood pressure. Timepoint: before and after intervention. Method of measurement: sphygmomanometer.;Total cholestrol. Timepoint: before and after intervention. Method of measurement: blood analysis.;HDL- cholestrol. Timepoint: before and after intervention. Method of measurement: blood analysis.;LDL-cholestrol. Timepoint: before and after intervention. Method of measurement: blood analysis.;Triglyceride. Timepoint: before and after intervention. Method of measurement: blood analysis.